78/100B107.380
USD
1.54
(1.46%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Edwards Lifesciences EPS (earnings per share) 1999–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
Edwards Lifesciences's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 0.53 USD, up 6.0% on the same quarter a year before. Edwards Lifesciences's diluted earnings per share over the last twelve months were 1.77 USD, down 23.7% on the twelve months before. In fiscal year 2025 they were 1.83 USD, down 73.7% on the year before.
Last updated 10 Nov 2026 · Next report 9 Feb 2027
EPS
Growth
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 1.77 | -23.71% | 1.77 |
| FY2025 | 31 Dec 2025 | 1.83 | -73.74% | 1.84 |
| FY2024 | 31 Dec 2024 | 6.97 | +203.04% | 6.98 |
| FY2023 | 31 Dec 2023 | 2.30 | -5.74% | 2.31 |
| FY2022 | 31 Dec 2022 | 2.44 | +2.52% | 2.46 |
| FY2021 | 31 Dec 2021 | 2.38 | +83.08% | 2.41 |
| FY2020 | 31 Dec 2020 | 1.30 | -20.73% | 1.32 |
| FY2019 | 31 Dec 2019 | 1.64 | +45.13% | 1.68 |
| FY2018 | 31 Dec 2018 | 1.13 | +17.71% | 1.15 |
| FY2017 | 31 Dec 2017 | 0.96 | +10.34% | 0.98 |
| FY2016 | 31 Dec 2016 | 0.87 | +16.00% | 0.89 |
| FY2015 | 31 Dec 2015 | 0.75 | -40.00% | 0.77 |
| FY2014 | 31 Dec 2014 | 1.25 | +119.30% | 1.27 |
| FY2013 | 31 Dec 2013 | 0.57 | +39.02% | 0.59 |
| FY2012 | 31 Dec 2012 | 0.41 | +24.24% | 0.43 |
| FY2011 | 31 Dec 2011 | 0.33 | +6.45% | 0.35 |
| FY2010 | 31 Dec 2010 | 0.31 | -6.06% | 0.32 |
| FY2009 | 31 Dec 2009 | 0.33 | +83.33% | 0.34 |
| FY2008 | 31 Dec 2008 | 0.18 | +12.50% | 0.19 |
| FY2007 | 31 Dec 2007 | 0.16 | -11.11% | 0.16 |
| FY2006 | 31 Dec 2006 | 0.18 | +63.64% | 0.19 |
| FY2005 | 31 Dec 2005 | 0.11 | +4,300.00% | 0.11 |
| FY2004 | 31 Dec 2004 | 0.00 | -97.73% | 0.00 |
| FY2003 | 31 Dec 2003 | 0.11 | +45.12% | 0.11 |
| FY2002 | 31 Dec 2002 | 0.08 | — | 0.08 |
| FY2001 | 31 Dec 2001 | -0.02 | — | -0.02 |
| FY2000 | 31 Dec 2000 | -0.39 | -425.00% | -0.39 |
| FY1999 | 31 Dec 1999 | 0.12 | — | 0.12 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.53 | +6.00% | 0.53 |
| Q2 FY2026 | 30 Jun 2026 | 0.42 | -25.00% | 0.42 |
| Q1 FY2026 | 31 Mar 2026 | 0.66 | +8.20% | 0.66 |
| Q4 FY2025 | 31 Dec 2025 | 0.16 | -75.38% | 0.16 |
| Q3 FY2025 | 30 Sept 2025 | 0.50 | -90.25% | 0.50 |
| Q2 FY2025 | 30 Jun 2025 | 0.56 | -8.20% | 0.57 |
| Q1 FY2025 | 31 Mar 2025 | 0.61 | +5.17% | 0.61 |
| Q4 FY2024 | 31 Dec 2024 | 0.65 | +6.56% | 0.65 |
| Q3 FY2024 | 30 Sept 2024 | 5.13 | +714.29% | 5.14 |
| Q2 FY2024 | 30 Jun 2024 | 0.61 | +22.00% | 0.61 |
| Q1 FY2024 | 31 Mar 2024 | 0.58 | +3.57% | 0.58 |
| Q4 FY2023 | 31 Dec 2023 | 0.61 | -6.15% | 0.61 |
| Q3 FY2023 | 30 Sept 2023 | 0.63 | +14.55% | 0.63 |
| Q2 FY2023 | 30 Jun 2023 | 0.50 | -23.08% | 0.51 |
| Q1 FY2023 | 31 Mar 2023 | 0.56 | -5.08% | 0.56 |
| Q4 FY2022 | 31 Dec 2022 | 0.65 | +22.64% | 0.65 |
| Q3 FY2022 | 30 Sept 2022 | 0.55 | +1.85% | 0.55 |
| Q2 FY2022 | 30 Jun 2022 | 0.65 | -16.67% | 0.65 |
| Q1 FY2022 | 31 Mar 2022 | 0.59 | +9.26% | 0.60 |
| Q4 FY2021 | 31 Dec 2021 | 0.53 | +8.16% | 0.54 |
| Q3 FY2021 | 30 Sept 2021 | 0.54 | +3.85% | 0.55 |
| Q2 FY2021 | 30 Jun 2021 | 0.78 | — | 0.79 |
| Q1 FY2021 | 31 Mar 2021 | 0.54 | +10.20% | 0.54 |
| Q4 FY2020 | 31 Dec 2020 | 0.49 | +11.36% | 0.50 |
| Q3 FY2020 | 30 Sept 2020 | 0.52 | +20.93% | 0.52 |
| Q2 FY2020 | 30 Jun 2020 | -0.20 | -152.63% | -0.20 |
| Q1 FY2020 | 31 Mar 2020 | 0.49 | +25.64% | 0.50 |
| Q4 FY2019 | 31 Dec 2019 | 0.44 | +4,300.00% | 0.45 |
| Q3 FY2019 | 30 Sept 2019 | 0.43 | +22.86% | 0.44 |
| Q2 FY2019 | 30 Jun 2019 | 0.38 | -13.64% | 0.39 |
| Q1 FY2019 | 31 Mar 2019 | 0.39 | +21.88% | 0.40 |
| Q4 FY2018 | 31 Dec 2018 | 0.01 | -81.88% | 0.01 |
| Q3 FY2018 | 30 Sept 2018 | 0.35 | +34.62% | 0.36 |
| Q2 FY2018 | 30 Jun 2018 | 0.44 | +51.72% | 0.45 |
| Q1 FY2018 | 31 Mar 2018 | 0.32 | -8.57% | 0.33 |
| Q4 FY2017 | 31 Dec 2017 | 0.06 | -77.00% | 0.06 |
| Q3 FY2017 | 30 Sept 2017 | 0.26 | +18.18% | 0.27 |
| Q2 FY2017 | 30 Jun 2017 | 0.29 | +52.63% | 0.29 |
| Q1 FY2017 | 31 Mar 2017 | 0.35 | +59.09% | 0.36 |
| Q4 FY2016 | 31 Dec 2016 | 0.24 | +14.29% | 0.25 |
| Q3 FY2016 | 30 Sept 2016 | 0.22 | +22.22% | 0.22 |
| Q2 FY2016 | 30 Jun 2016 | 0.19 | +11.76% | 0.20 |
| Q1 FY2016 | 31 Mar 2016 | 0.22 | +15.79% | 0.22 |
| Q4 FY2015 | 31 Dec 2015 | 0.21 | +23.53% | 0.22 |
| Q3 FY2015 | 30 Sept 2015 | 0.18 | +28.57% | 0.18 |
| Q2 FY2015 | 30 Jun 2015 | 0.17 | -80.00% | 0.18 |
| Q1 FY2015 | 31 Mar 2015 | 0.19 | +103.64% | 0.19 |
| Q4 FY2014 | 31 Dec 2014 | 0.17 | +54.55% | 0.17 |
| Q3 FY2014 | 30 Sept 2014 | 0.14 | +27.27% | 0.15 |
| Q2 FY2014 | 30 Jun 2014 | 0.85 | +507.14% | 0.86 |
| Q1 FY2014 | 31 Mar 2014 | 0.09 | -55.57% | 0.10 |
| Q4 FY2013 | 31 Dec 2013 | 0.11 | -15.38% | 0.12 |
| Q3 FY2013 | 30 Sept 2013 | 0.11 | +13.75% | 0.12 |
| Q2 FY2013 | 30 Jun 2013 | 0.14 | +47.37% | 0.14 |
| Q1 FY2013 | 31 Mar 2013 | 0.21 | +129.01% | 0.21 |
| Q4 FY2012 | 31 Dec 2012 | 0.13 | +47.23% | 0.13 |
| Q3 FY2012 | 30 Sept 2012 | 0.10 | +34.87% | 0.10 |
| Q2 FY2012 | 30 Jun 2012 | 0.10 | +18.75% | 0.10 |
| Q1 FY2012 | 31 Mar 2012 | 0.09 | +3.85% | 0.10 |
| Q4 FY2011 | 31 Dec 2011 | 0.09 | -7.15% | 0.09 |
| Q3 FY2011 | 30 Sept 2011 | 0.07 | +7.50% | 0.08 |
| Q2 FY2011 | 30 Jun 2011 | 0.08 | 0.00% | 0.09 |
| Q1 FY2011 | 31 Mar 2011 | 0.09 | +32.38% | 0.09 |
| Q4 FY2010 | 31 Dec 2010 | 0.10 | +35.28% | 0.10 |
| Q3 FY2010 | 30 Sept 2010 | 0.07 | -33.30% | 0.07 |
| Q2 FY2010 | 30 Jun 2010 | 0.08 | +18.52% | 0.09 |
| Q1 FY2010 | 31 Mar 2010 | 0.07 | -22.26% | 0.07 |
| Q4 FY2009 | 31 Dec 2009 | 0.07 | +23.99% | 0.07 |
| Q3 FY2009 | 30 Sept 2009 | 0.10 | +114.13% | 0.11 |
| Q2 FY2009 | 30 Jun 2009 | 0.07 | +20.97% | 0.07 |
| Q1 FY2009 | 31 Mar 2009 | 0.09 | +232.56% | 0.09 |
| Q4 FY2008 | 31 Dec 2008 | 0.06 | +145.45% | 0.06 |
| Q3 FY2008 | 30 Sept 2008 | 0.05 | +16.75% | 0.05 |
| Q2 FY2008 | 30 Jun 2008 | 0.06 | +17.47% | 0.06 |
| Q1 FY2008 | 31 Mar 2008 | 0.03 | -42.67% | 0.03 |
| Q4 FY2007 | 31 Dec 2007 | 0.02 | -21.96% | 0.02 |
| Q3 FY2007 | 30 Sept 2007 | 0.04 | +6.67% | 0.04 |
| Q2 FY2007 | 30 Jun 2007 | 0.05 | -1.66% | 0.05 |
| Q1 FY2007 | 31 Mar 2007 | 0.05 | -25.99% | 0.05 |
| Q4 FY2006 | 31 Dec 2006 | 0.03 | -44.98% | 0.03 |
| Q3 FY2006 | 30 Sept 2006 | 0.04 | — | 0.04 |
| Q2 FY2006 | 30 Jun 2006 | 0.05 | +163.93% | 0.05 |
| Q1 FY2006 | 31 Mar 2006 | 0.06 | +45.80% | 0.06 |
| Q4 FY2005 | 31 Dec 2005 | 0.05 | +48.62% | 0.05 |
| Q3 FY2005 | 30 Sept 2005 | -0.01 | -136.53% | -0.01 |
| Q2 FY2005 | 30 Jun 2005 | 0.02 | -46.49% | 0.02 |
| Q1 FY2005 | 31 Mar 2005 | 0.04 | — | 0.04 |
| Q4 FY2004 | 31 Dec 2004 | 0.04 | +36.09% | 0.04 |
| Q3 FY2004 | 30 Sept 2004 | 0.02 | -49.85% | 0.02 |
| Q2 FY2004 | 30 Jun 2004 | 0.03 | +20.85% | 0.04 |
| Q1 FY2004 | 31 Mar 2004 | -0.09 | -534.00% | -0.09 |
| Q4 FY2003 | 31 Dec 2003 | 0.03 | -13.64% | 0.03 |
| Q3 FY2003 | 30 Sept 2003 | 0.03 | — | 0.03 |
| Q2 FY2003 | 30 Jun 2003 | 0.03 | -32.13% | 0.03 |
| Q1 FY2003 | 31 Mar 2003 | 0.02 | -29.33% | 0.02 |
| Q4 FY2002 | 31 Dec 2002 | 0.03 | +32.19% | 0.03 |
| Q3 FY2002 | 30 Sept 2002 | -0.02 | -223.50% | -0.02 |
| Q2 FY2002 | 30 Jun 2002 | 0.04 | — | 0.04 |
| Q1 FY2002 | 31 Mar 2002 | 0.03 | +61.71% | 0.03 |
| Q4 FY2001 | 31 Dec 2001 | 0.02 | -34.18% | 0.02 |
| Q3 FY2001 | 30 Sept 2001 | 0.02 | +244.83% | 0.02 |
| Q2 FY2001 | 30 Jun 2001 | -0.08 | — | -0.08 |
| Q1 FY2001 | 31 Mar 2001 | 0.02 | -27.69% | 0.02 |
| Q4 FY2000 | 31 Dec 2000 | 0.04 | +23.34% | 0.04 |
| Q3 FY2000 | 30 Sept 2000 | 0.01 | — | 0.01 |
| Q2 FY2000 | 30 Jun 2000 | -0.44 | — | -0.44 |
| Q1 FY2000 | 31 Mar 2000 | 0.02 | — | 0.02 |
| Q4 FY1999 | 31 Dec 1999 | 0.03 | — | 0.03 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Edwards Lifesciences's EPS
Source: Financial Modeling Prep